
COVID-19 and Monkeypox Updates
Key Points: In today’s Recommendation for Industry, we provide updates on COVID-19 and Monkeypox. Read more below. Pfizer’s Omicron-Targeting COVID-19 Vaccines Generate Stronger Immune Response.

Key Points: In today’s Recommendation for Industry, we provide updates on COVID-19 and Monkeypox. Read more below. Pfizer’s Omicron-Targeting COVID-19 Vaccines Generate Stronger Immune Response.

Key Points: In today’s Recommendation for Industry, we discuss the encouraging trajectory of COVID based on TAG’s matrix and CDC’s mapping. Read more below. Women

Key Points: In today’s Recommendation for Industry, we discuss the low risk of monkeypox in the US, and what businesses can do to keep it

Key Points: In today’s Recommendation for Industry, we discuss the current data on COVID case rates and hospitalizations. Read more below. FDA committee approves Moderna

Key Points: In today’s Recommendation for Industry, we discuss the recent monkeypox outbreak. Read more below. In-utero COVID exposure tied to language, motor delays by

Key Points: In today’s Recommendation for Industry, we discuss the westward movement of COVID and increase of BA.4 and BA. 5 in the U.S. Read

Key Points: In today’s Recommendation for Industry, we discuss defending against infectious disease. Read more below. COVID-19 vaccine during pregnancy may protect infants. The COVID-19

CDC’s review of the epidemiological information on the recent Salmonella Senftenberg peanut butter outbreak indicated that five of five people consumed peanut butter and four

Key Points: Influenza: Public Health & Food Safety: Recommendations for Industry Prepare Your Business for Omicron Variant Reinfections With CDC’s community level maps showing a

Key Points: In today’s Recommendations for Industry, we discuss keeping ill workers home to reduce both infectious and foodborne diseases. Read more below. To handle